Rezultati - C. Britten

SUPRAME: A Phase 3 trial evaluating anzutresgene autoleucel (anzu-cel, IMA203) PRAME-directed T-cell receptor T-cell therapy vs investigator’s choice in previously treated advanced... od A. Betof, M. Jalving, J. Haanen, A. van der Veldt, F. Schmitz, A. Busse, D. Schadendorf, J. Hassel, E. Wagner, C. Gebhardt, B. Schilling, C. Berking, S. Patel, D. Davar, L. Hernandez-Aya, A.J. Olszanski, J. Smithy, L. Karapetyan, Y. Xing, S. Hu-Lieskovan, J. Isaacs, M. Hurwitz, R. Wu, A. Poklepovic, M. Taylor, T. Mitchell, B. Chmielowski, S. Lee, M. McKean, C. Cowey, S. Moschos, A. Haugh, J. Moser, B. Sharma, J.M. Mammen, M. Dimitrova, R. Amaria, R. Seedor, P. Hausner, S. Chandrasekaran, E. Whitman, D. Olson, V. Ma, A.Z. Dudek, L. Fecher, A. Daud, D. McDermott, H. Viray, B. Solomon, G. Daniels, R. Chen, M. Seetharam, D. Sahasrabudhe, S. Nair, A.R. Naqash, J. Terhune, C. Robert, C. Lebbe, L. Mortier, J.C. Simon, C. Franklin, M.O. Butler, A. Weppler, M. Anaka, R. Jamal, D. Josephs, Y. Wu, P. Corrie, P. Spiliopoulou, J. Lim, I. Karydis, M. Payne, A. Furness, H. Shaw, D. Krishna, C. Britten, M. Wermke

Polni tekst